PTGX

NASDAQStock

Protagonist Therapeutics, Inc.

$96.17-0.39 (-0.40%)

52-Week Range

$40.89
$97.05

Key Stats

Market Cap

6.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.24

Volume

467.9K

Avg Volume

703.2K

Performance

1M

+13.76%

3M

+0.07%

6M

+63.45%

YTD

+9.45%

1Y

+65.52%

3Y

+275.97%

5Y

+209.50%

Price Chart

ETF Exposure

PTGX is held by 130 ETFs

ETFFund NameWeight
PSCHInvesco S&P SmallCap Health Care ETF3.46%
PBEInvesco Biotechnology & Genome ETF3.18%
PTHInvesco Dorsey Wright Healthcare Momentum ETF2.25%
BMEDiShares Health Innovation Active ETF1.72%
RZGInvesco S&P SmallCap 600 Pure Growth ETF1.55%
XSMOInvesco S&P SmallCap Momentum ETF1.30%
XBIState Street SPDR S&P Biotech ETF1.30%
FDMOFIDELITY MOMENTUM FACTOR ETF0.76%
BBCVirtus Biotech Clinical Trials ETF0.75%
SLYGState Street SPDR S&P 600 Small Cap Growth ETF0.74%
IJTiShares S&P Small-Cap 600 Growth ETF0.74%
FLQSFranklin U.S. Small Cap Multifactor Index ETF0.67%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.66%
VAMOCambria Value & Momentum ETF0.64%
SVALiShares US Small Cap Value Factor ETF0.64%
VIOGVanguard S&P Small-Cap 600 Growth ETF0.61%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.56%
ACSGAmerican Century Small Cap Growth Insights ETF0.54%
SCDSJPMorgan Fundamental Data Science Small Core ETF0.54%
ETHOAmplify Etho Climate Leadership U.S. ETF0.54%
IBBiShares Biotechnology ETF0.50%
LOPPGabelli Love Our Planet & People ETF0.50%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.49%
IBBQInvesco Nasdaq Biotechnology ETF0.46%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF0.45%
IWOiShares Russell 2000 Growth ETF0.45%
SMMViShares MSCI USA Small-Cap Min Vol Factor ETF0.44%
XJRiShares ESG Select Screened S&P Small-Cap ETF0.44%
PSCPrincipal U.S. Small-Cap Multi-Factor ETF0.43%
QVMSInvesco S&P SmallCap 600 QVM Multi-factor ETF0.43%
IJRiShares Core S&P Small-Cap ETF0.38%
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETF0.38%
JMEEJPMorgan Small & Mid Cap Enhanced Equity ETF0.37%
AFSMFirst Trust Active Factor Small Cap ETF0.36%
TNXTT. Rowe Price Innovation Leaders ETF0.33%
JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF0.32%
BIBProShares - Ultra Nasdaq Biotechnology0.31%
VIOOVanguard S&P Small-Cap 600 ETF0.31%
OASCOneAscent Small Cap Core ETF0.30%
VTWGVanguard Russell 2000 Growth ETF0.30%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF0.29%
STXKStrive Small-Cap ETF0.29%
ROSCHartford Multifactor Small Cap ETF0.28%
BKSEBNY Mellon US Small Cap Core Equity ETF0.28%
SAAProShares - Ultra SmallCap6000.27%
USVMVictoryShares US Small Mid Cap Value Momentum ETF0.27%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.26%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.25%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.22%
CSAVictoryShares US Small Cap Volatility Wtd ETF0.22%
Page 1 of 3Next

About PTGX ETF Exposure

Protagonist Therapeutics, Inc. (PTGX) is held by 130 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.1B, PTGX is a widely held institutional stock. The stock currently trades at $96.17. Investors can gain exposure to PTGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTGX, sorted by portfolio weight.